TagsGenomics

Tag: Genomics

Stories

Magnitude of genomic sequencing is undervalued in India to fight pandemic

Aishwarya Ingle - June 10, 2021 0

Trends

Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19

surbhi - April 2, 2020 0

STARTUPS

Color is launching a high-capacity COVID-19 testing lab and will open-source its design and protocols

surbhi - March 31, 2020 0

Trends

Karius raises $165 million for its liquid biopsy technology identifying diseases in a drop of blood

Nitin Naresh - February 24, 2020 0

Trends

XGenomes is bringing DNA sequencing to the masses

Nitin Naresh - March 15, 2019 0

Stories

DNA Startup Nebula Genomics Offering Free DNA Sequencing to Everyone

Nitin Naresh - November 19, 2018 0

Most Read

Top 5 Best Cloud Hosting Companies in India 2024

May 4, 2024

Top 10 Best Retail Tech Companies in India 2024

May 4, 2024

Top 10 Best SMS Marketing Companies in India 2024

May 4, 2024

Top 10 Best POS In India 2024

May 4, 2024

EDITOR PICKS

Top 5 Best Cloud Hosting Companies in India 2024

May 4, 2024

Top 10 Best Retail Tech Companies in India 2024

May 4, 2024

Top 10 Best SMS Marketing Companies in India 2024

May 4, 2024

POPULAR POSTS

Bird Flu: Another Pandemic Swallowing India

January 11, 2021

Indian Railways labels “superfast” status to 130 more trains, increases fares

October 28, 2022

ABES College Faces Cultural Crossroads: ‘Jai Shri Ram’ Controversy Leads to Suspension Of Two Professors

October 22, 2023

ABOUT US

Inventiva is a business Magazine covering startups, entrepreneurs & their journey. We bring some of the most talented, different & potential & motivational entrepreneurs.

Contact us: info@inventiva.co.in

FOLLOW US

© Inventiva Brand Of Nine Network Private Limited. Nine Network A Company Registered Under Indian Companies Act 2013 And Registered As Nine Network Private Limited CIN: U74140DL2016PTC289760. Inventiva Is A Fully Licensed & Registered Print Media With RNI Under MIB Registration Number DELBIL/2018/76160.